Document is current
Any future updates will be listed below
-
Authors
Shimizu, Yoichi https://orcid.org/0000-0002-5154-090X
Tsuji, Katsunori https://orcid.org/0000-0003-0508-6774
Ochi, Eisuke https://orcid.org/0000-0002-2497-0250
Okubo, Ryo https://orcid.org/0000-0002-1254-1926
Kuchiba, Aya https://orcid.org/0000-0002-6786-3527
Shimazu, Taichi https://orcid.org/0000-0001-6000-9830
Tatematsu, Noriatsu
Sakurai, Naomi
Iwata, Hiroji https://orcid.org/0000-0002-0242-4718
Matsuoka, Yutaka J. https://orcid.org/0000-0002-8690-8129
-
Funding
Funding for this research was provided by:
National Cancer Center Japan (30-A-17)
- License Information
-
More Information
Article History
Received: 12 July 2021
Accepted: 16 November 2021
First Online: 1 December 2021
Declarations
:
: This survey of OCPs did not collect identifying personal information or ask invasive questions. The institutional review board of the National Cancer Center Japan waived the need for ethics review. We conducted the survey with approval from the chair of the National Cancer Center Japan and the academic committee of the JBCS. We conducted the survey in accordance with the policies outlined in relevant ethical guidelines such as the Declaration of Helsinki, with due consideration given to the protection of individuals.
: Consent to participate was obtained by marking a check box provided with the study prospectus.
: All authors consent to publication of this article in <i>Supportive Care in Cancer</i>.
: EO has received research support from Nippon Suisan Kaisha, Ltd. YJM has received speaker fees from Suntory Wellness, Pfizer, Mochida, Eli Lilly, Morinaga Milk, and Cimic and is conducting collaborative research with Susmed. AK has received speaking fees from Chugai Pharmaceutical Co., Ltd. All other authors declare that they have no competing interests regarding this work.
